Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more
Market Cap & Net Worth: Demant A/S (WILLF)
Demant A/S (PINK:WILLF) has a market capitalization of $6.87 Billion ($6.87 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #3985 globally and #2537 in its home market, demonstrating a -13.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Demant A/S's stock price $32.58 by its total outstanding shares 210898609 (210.90 Million).
Demant A/S Market Cap History: 2016 to 2025
Demant A/S's market capitalization history from 2016 to 2025. Data shows growth from $3.57 Billion to $6.87 Billion (6.98% CAGR).
Demant A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Demant A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.30x
Demant A/S's market cap is 0.30 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
4.46x
Demant A/S's market cap is 4.46 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.57 Billion | $12.00 Billion | $1.46 Billion | 0.30x | 2.45x |
| 2017 | $5.80 Billion | $13.19 Billion | $1.75 Billion | 0.44x | 3.31x |
| 2018 | $5.91 Billion | $13.94 Billion | $1.82 Billion | 0.42x | 3.24x |
| 2019 | $6.68 Billion | $14.95 Billion | $1.46 Billion | 0.45x | 4.57x |
| 2020 | $7.61 Billion | $14.47 Billion | $1.12 Billion | 0.53x | 6.79x |
| 2021 | $9.83 Billion | $17.91 Billion | $2.51 Billion | 0.55x | 3.91x |
| 2022 | $5.64 Billion | $19.70 Billion | $2.08 Billion | 0.29x | 2.71x |
| 2023 | $9.28 Billion | $22.44 Billion | $1.79 Billion | 0.41x | 5.17x |
| 2024 | $7.64 Billion | $22.42 Billion | $2.39 Billion | 0.34x | 3.20x |
| 2025 | $6.87 Billion | $23.03 Billion | $1.54 Billion | 0.30x | 4.46x |
Competitor Companies of WILLF by Market Capitalization
Companies near Demant A/S in the global market cap rankings as of March 18, 2026.
Key companies related to Demant A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Demant A/S Historical Marketcap From 2016 to 2025
Between 2016 and today, Demant A/S's market cap moved from $3.57 Billion to $ 6.87 Billion, with a yearly change of 6.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.87 Billion | -10.09% |
| 2024 | $7.64 Billion | -17.64% |
| 2023 | $9.28 Billion | +64.48% |
| 2022 | $5.64 Billion | -42.63% |
| 2021 | $9.83 Billion | +29.24% |
| 2020 | $7.61 Billion | +13.95% |
| 2019 | $6.68 Billion | +13.07% |
| 2018 | $5.91 Billion | +1.82% |
| 2017 | $5.80 Billion | +62.24% |
| 2016 | $3.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Demant A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.87 Billion USD |
| MoneyControl | $6.87 Billion USD |
| MarketWatch | $6.87 Billion USD |
| marketcap.company | $6.87 Billion USD |
| Reuters | $6.87 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.